TABLE 1.
Clinical characteristics of the children with congenital hyperinsulinism
| SUR1 genotype | Patient number | Sex | Age (years) | Age at presentation | Age at pancreatectomy | Current treatment |
|---|---|---|---|---|---|---|
| Diffuse hyperinsulinism | ||||||
| DelF 1388/3992 –9 g → a | 1 | F | 20 | 4 h | 2 months | Frequent feedings |
| DelF 1388/3992 –9 g → a | 2 | F | 14 | Newborn | 8 days | None |
| DelF 1388/3992 –9 g → a | 3 | F | 13 | 11 months | ND* | None since age 8 years |
| DelF 1388/3992 –9 g → a | 4 | M | 2 | 3 days | 1, 2, 30 months* | Glucagon-octreotide infusion |
| 3992 –9 g → a/3992 –9 g → a | 5 | M | 13 | 10 days | ND | Frequent feedings |
| 3992 –9 g → a/3992 –9 g → a | 6 | M | 11 | 2 days | ND | Frequent gastrostomy feedings |
| 3992 –9 g → a/3992 –9 g → a | 7 | F | 6 | 1–2 days | 1 month | None |
| 3992 –9 g → a/3992 –9 g → a | 8 | M | 4 | At birth | 1 month | None |
*
Surgery done after the time of the study; ND, no surgery.